---
title: 'Iron and other metals in the pathogenesis of Parkinson''s disease: Toxic effects
  and possible detoxification'
type: pub
encoding: UTF-8

---
<h1>Publikasjon</h1>
<article id="csl-bib-container-P5MKRDAJ" class="csl-bib-container">
  <div class="csl-bib-body"> <div class="csl-entry">Bjørklund, G., Hofer, T., Nurchi, V. M., &#38; Aaseth, J. (2019). Iron and other metals in the pathogenesis of Parkinson’s disease: Toxic effects and possible detoxification. <i>Journal of Inorganic Biochemistry</i>, <i>199</i>. <a href="https://doi.org/10.1016/j.jinorgbio.2019.110717">https://doi.org/10.1016/j.jinorgbio.2019.110717</a></div> </div>
  <div class="csl-bib-buttons">
    <a href="#taxonomy-article-P5MKRDAJ" alt="archive" class="csl-bib-button">Arkiv</a>
    <a href="https://app.cristin.no/results/show.jsf?id=1715238" alt="Cristin" class="csl-bib-button">Cristin</a>
    <a href="http://zotero.org/groups/5881554/items/P5MKRDAJ" alt="Zotero" class="csl-bib-button">Zotero</a>
    <a href="#keywords-article-P5MKRDAJ" alt="keywords" class="csl-bib-button">Emneord</a>
    <a href="#about-article-P5MKRDAJ" alt="about_pub" class="csl-bib-button">Om</a>
    <a href="#sdg-article-P5MKRDAJ" alt="sdg" class="csl-bib-button">Berekraftsmål</a>
    <a href="https://doi.org/10.1016/j.jinorgbio.2019.110717" alt="Unpaywall" class="csl-bib-button">Unpaywall</a>
    <a href="https://doi.org/10.1016/j.jinorgbio.2019.110717" alt="EZproxy" class="csl-bib-button">EZproxy</a>
  </div>
  <div id="csl-bib-meta-container-P5MKRDAJ"></div>
</article>
<div id="csl-bib-meta-P5MKRDAJ" class="csl-bib-meta">
  <article id="about-article-P5MKRDAJ" class="about_pub-article">
    <h1>Om</h1>
    Bjørklund et al. undersøkte rolla til metall som jern i utviklinga av Parkinsons sjukdom (PD). Dei fann at miljøfaktorar, inkludert eksponering for metall som jern, kvikksølv, mangan og bly, kan bidra til PD. Auka jernnivå i hjernen sitt substantia nigra-område vart særleg notert hos PD-pasientar. Dette overskytande jernet, kombinert med auka reaktive oksygenforbindelsar (ROS), forstyrrar dopaminproduksjonen, noko som fører til nevrotransmittordysfunksjon. Forfattarane foreslår at bruk av kjeleringsterapi, som involverer stoff som bind til og fjernar metall, kan bidra til å sakke ned progresjonen av PD. Behandlingar som deferipron, apomorfin og hinokitiol, samt kroppens naturlege kjelator, neuromelanin, viser lovande resultat i å beskytte mot PD. Denne studien framhevar viktigheita av å handtere metalleksponering for potensielt å redusere risikoen for PD.
  </article>
  <article id="keywords-article-P5MKRDAJ" class="keywords-article">
    <h1>Emneord</h1>
    Parkinsons sjukdom, Jern, Metall, Mitokondriell dysfunksjon, Reaktive oksygenforbindelsar, Kjeleringsterapi
  </article>
  <article id="abstract-article-P5MKRDAJ" class="abstract-article">
    <h1>Samandrag</h1>
    Abstract 
 
 
Of the documented cases of Parkinson's disease (PD), about 10% have a genetic background. The remaining cases of PD have unknown etiology. Thus, environmental factors appear to play a pathogenic role in most of the PD cases. Several of the so far known PD inducing chemicals appear to increase the formation of mitochondrial reactive oxygen species (ROS). A suspected environmental factor is the non-proteinogenic amino acid β-methylamino-l-alanine (BMAA), which may act to carry iron species into the brain and disrupt correct biosynthesis of proteins. In addition, in epidemiological studies, it has been reported a connection between PD and metal exposures, including iron, mercury, manganese, and lead. Research has shown elevated iron levels in the substantia nigra of PD patients. Mitochondrial dysfunction induced by genetic or environmental factors appears to evoke cascades of biochemical events, which include non-physiological leakage of ROS and arrest of the sensitive production of dopamine. A combination of increased ROS and loosely chelated iron causes neurotransmitter dysfunction. Recent research indicates that treatment with exogenous chelators, such as deferiprone, apomorphine, and hinokitiol, can inhibit PD progression. The endogenous chelator, neuromelanin, also appears to exert protection. In the present review, the pathogenic mechanisms and genetic susceptibilities to metals in PD are explored. The paper is also focused on strategies for the therapy of PD, mainly by using chelation therapy to reduce the level of iron.
  </article>
  <article id="sdg-article-P5MKRDAJ" class="sdg-article">
    <h1>Berekraftsmål</h1>
    <div class="sdg-container"><div id="sdg3" class="sdg">
        <img src="{{< params subfolder >}}images/sdg/sdg03_nn.png" class="image" alt="SDG 3">
        <div class="sdg-overlay">
          <a href="{{< params subfolder >}}nn/archive/?sdg=3#archive" class="sdg-publication-count"><span>1358</span> publikasjonar</a>
          <p><a href="https://fn.no/om-fn/fns-baerekraftsmaal/god-helse-og-livskvalitet?lang=nno-NO" class="sdg-read-more">Les meir</a></p>
        </div>
      </div></div>
  </article>
  <article id="taxonomy-article-P5MKRDAJ" class="taxonomy-article">
    <h1>Arkiv</h1>
    <ul>
      <li><a href="{{< params subfolder >}}nn/archive/?key=3DCRN523">Universitetet i Innlandet</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=IDKFS3MX">Fakultet for helse- og sosialvitenskap</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=GTV4ECMZ">Institutt for helse- og sykepleievitenskap</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=E7THIEEM">2019</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=RVVJX4EK">August</a></li>
    </ul>
  </article>
</div>
